Indication and use of drug products used to treat attention-deficit/ hyperactivity disorder: A cross-sectional study with inference on the likelihood of treatment in adulthood

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 3, 2007, Pages 328-333

  Brinker, Allen ^a   Mosholder, Andrew ^a   Schech, Stephanie D ^b   Burgess, Margaret ^b   Avigan, Mark ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Center for Health Care Policy and Evaluation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; ADULT DISEASE; ADULTHOOD; AGE DISTRIBUTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; DRUG INDICATION; DRUG USE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PATIENT CODING; PHYSICIAN; PRESCRIPTION; PREVALENCE;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; INFANT; INSURANCE CLAIM REVIEW; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROPYLAMINES;

EID: 34447540019     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.0062     Document Type: Article

References (8)

1. Biederman J, Mick E, Faraone SV: Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am J Psychiatry 157:816-818, 2000.
2. Centers for Disease Control and Prevention. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States, 2003. MMWR 54:842-847, 2005.
3. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustün TB, Zaslavsky AM: Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: Results from the national comorbidity survey replication. Biol Psychiatry 57:1442-1451, 2005.
4. The National Children's Study is led by a consortium of federal agency partners: The U.S. Department of Health and Human Services (including the National Institute of Child Health and Human Development and the National Institute of Environmental Health Sciences, two parts of the National Institutes of Health, and the Centers for Disease Control and Prevention), and the U.S. Environmental Protection Agency (EPA). See http://nationalchildrensstudy. gov/. Accessed February 22, 2006.
5. Rappley MD: Clinical practice. Attention deficit-hyperactivity disorder. N Engl J Med 352:165-173, 2005.
6. Rasmussen P, Gillberg C: Natural outcome of ADHD with developmental coordination disorder at age 22 years: A controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39:1424-1431, 2000.
7. Weiss M, Murray C, Weiss G, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Adults with attention-deficit/hyperactivity disorder: Current concepts. J Psychiatry Pract 8:99-111, 2002.
8. Zito JM, Safer DJ, dosReis S, et al: Psychotropic practice patterns for youth: A 10-year perspective. Arch Pediatr Adolesc Med 157:17-25, 2003.